ABIOMED, INC. Inactive Instrument
Abiomed, Inc. Stock
Equities
ABMD
US0036541003
Advanced Medical Equipment & Technology
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
More news
More recommendations
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Thorsten Sieß
CEO | Chief Executive Officer | - | 04-12-31 |
Todd Tetreault
DFI | Director of Finance/CFO | - | 22-12-31 |
| President | 51 | 04-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Fortunati
BRD | Director/Board Member | - | 22-12-21 |
Vincent Sommella
BRD | Director/Board Member | - | 22-12-21 |
Susan Morano
BRD | Director/Board Member | - | 22-12-21 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.44% | 0 M€ | +5.71% | - | |
| 0.33% | 0 M€ | +8.89% |
Abiomed, Inc. specializes in the development, manufacturing and marketing of medical devices to assist or replace the pumping function of the failing heart. Net sales break down by activity as follows:
- sale of products (95.4%): heart pumps (Impella brand);
- sale of services (4.6%): including preventive maintenance services.
Net sales are distributed geographically as follows: the United States (81.2%), Europe (12.8%), Japan (5%) and other (1%).
| 1st Jan change | Capi. | |
|---|---|---|
| +8.07% | 219B | |
| +7.87% | 185B | |
| +12.75% | 135B | |
| -1.37% | 62.21B | |
| +4.88% | 51.01B | |
| +11.59% | 51.28B | |
| +2.71% | 41.85B | |
| +4.90% | 37.02B | |
| +23.75% | 31.27B |